Drugs & Targets FDA publishes draft guidance on optimizing dosage for oncology drugs January 20, 2023Vol.49 No.03
Drugs & Targets Strata Oncology adds Gilead as Strata PATH Trial collaborator January 20, 2023Vol.49 No.03
Drugs & Targets Elicio Therapeutics and Angion enter into merger agreement to advance cancer vaccine January 20, 2023Vol.49 No.03
Conversation with The Cancer Letter Jedd Wolchok: Weill Cornell’s path to NCI designation runs through Brooklyn and Queens January 13, 2023Vol.49 No.02By Paul Goldberg
Guest Editorial Ending cancer as we know it—for everyone—begins with the numbers January 13, 2023Vol.49 No.02By William L. Dahut
In Brief Wm. Kevin Kelly appointed chair of medical oncology at Thomas Jefferson January 13, 2023Vol.49 No.02
In Brief Faye Rogers named associate cancer center director for DEI at Yale January 13, 2023Vol.49 No.02
